Relevance of GADF15 biomarker with left ventricular ejection fraction in coronary artery disease (CAD ) patients

Authors

• Ola Muslim Alhussainy, Medical Biochemistry , College of Medicine , University of AL – QadisiyahFollow
• Haider Abd Jabbar ALammar, Department of Biochemistry, College of Medicine, University of Al-Qadisiyah/Iraq
• Aqeel Raheem Hassan, College of Medicine , University of AL – Qadisiyah

Abstract

     The  correlation of new biomarkers with In patients with coronary artery disease (CAD), left ventricular ejection fraction.Globally, coronary artery disease is a significant non-communicable disease issue. Numerous significant risk factors, including smoking, diabetes mellitus, dyslipidemia, and hypertension, can result in coronary artery disease. [1]. patient heart failure management. When following up on heart failure cohorts over an extended period of time, plasma BNP or NT-proBNP is a highly effective independent predictor of death and morbidity. Furthermore, it seems to be a reliable indicator of a positive reaction when beta blocker is added to anti-heart failure medication. When changing therapy for heart failure based on serial measures of NT-proBNP, as opposed to altering therapy based on independent clinical judgment, better results are expected.

Article Type

Article

First Page

85

Last Page

89

Rights

Copyright (c) 2024 2024

Recommended Citation

Alhussainy, Ola Muslim; ALammar, Haider Abd Jabbar; and Hassan, Aqeel Raheem (2026) "Relevance of GADF15 biomarker with left ventricular ejection fraction in coronary artery disease (CAD ) patients," Al-Qadisiyah Medical Journal: Vol. 20: Iss. 2, Article 5.
DOI: https://doi.org/10.28922/2312-7864.1667